BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 2747321)

  • 1. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
    del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
    Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute leukemia. Case material and therapeutic results].
    Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
    Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH;
    Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
    Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
    Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
    [No Abstract]   [Full Text] [Related]  

  • 7. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late results of the treatment of acute granulocytic leukemia in adults].
    Perilov AA; Volkova MA; Frenkel' MA
    Ter Arkh; 1989; 61(7):8-11. PubMed ID: 2588148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of 2 chemotherapy protocols in adult acute myeloblastic leukemia. Results of the Instituto Nacional de la Nutrición Salvador Zubirán cooperative group].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ; Labardini-Méndez J; Gómez-Almaguer D; Ganci-Cerrud G; Lozano-de-la-Vega A
    Rev Invest Clin; 1992; 44(1):63-9. PubMed ID: 1523351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute myeloblastic leukemia in adults: evaluation of the AML 06/96 protocol].
    Qachouh M; Quessar A; Harif M; Benchekroun S
    Tunis Med; 2003 Jul; 81(7):461-5. PubMed ID: 14534956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [4'-(9-acridinylamino)-methanesulfon-m-aniside (AMSA) combination salvage therapy in refractory acute non-lymphocytic leukemia in adults].
    Mukaiyama T; Ogawa M; Horikoshi N; Inoue K; Fukutani H; Tabata M; Hirano A; Mizunuma N; Itami S
    Gan To Kagaku Ryoho; 1989 May; 16(5):2019-23. PubMed ID: 2730091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of adult acute myelogenous leukemia: a pilot study at Chulalongkorn Hospital.
    Intragumtornchai T; Sucharitchan P; Swasdikul D; Mahasandhana S; Watananukul P
    J Med Assoc Thai; 1991 Jul; 74(7):265-71. PubMed ID: 1765741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
    Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
    Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myeloid leukemia in the adult. Results of the National Antineoplastic Drug Protocol at the Hospital del Salvador, 1990-1998].
    Puga BL; Cabrera ME; Undurraga MS; Etcheverry R; Vacarezza R; Ducach G; Toledo H
    Rev Med Chil; 2000 Nov; 128(11):1191-8. PubMed ID: 11347505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy.
    Kyo T; Dohy H
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1641-52. PubMed ID: 3247827
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities for the cure of acute myeloblastic leukemia with the modified VAPA regimen: preliminary results].
    Díaz Mediavilla J; del Potro Gómez E; Llorente Pérez L; Martínez Martínez R; Guerra Moyano JL; de la Vega Bueno E; Alvarez Carmona A; Krsnik Castelló I; Alarcón Zurita C; Rodríguez Vázquez M
    Med Clin (Barc); 1984 Dec; 83(19):783-6. PubMed ID: 6597329
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
    Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
    Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.